Epilepsy and paroxysmal conditions

Advanced search

“Suicidal passport” for epilepsy

Full Text:


Background. Over the past decades many Russian and foreign authors have devoted their studies to psychiatric comorbidity and suicidal behaviour in people with epilepsy. It is particularly important to find risk factors to develop suicidal ideation in this group of patients. According to the World Health Organisation, suicide is the second cause of death among patients with epilepsy, especially those under 29 years. Social maladaptation and deviant reactions to isolation within the framework of personality disorder and frustrating elements necessitate strategy development to prevent suicide intentions in this group of patients.
Objective: to find risk factors contributing to suicidal behaviour in patients with epilepsy.
Material and methods. We examined 102 patients diagnosed with epilepsy and divided them into two groups consistent with the available relevant suicide ideators: Group 1 (reference group) – without suicide ideators (n=73), Group 2 (study group) – with suicide ideators at the time of the study (n=29). We conducted a pathopsychological study using scales and questionnaires.
Results. Patients with epilepsy and suicidal ideation are more vulnerable to a wide range of mental health disorders. Behavioural and mood disorders predominate. Risk factors for suicide in this patient cohort relate to a darker outlook on the future and emotional instability. All limits of the antisuicidal behaviour pattern reduced uniformly, except for the Family responsibility. Amidst the severe course of the underlying medical conditions, disharmony is formed in attitude towards the disease.
Conclusion. Assessment of the risk factors for the development of suicidal ideation in patients with epilepsy is a challenging multidisciplinary task. Even with relative mental well-being, it is worth focusing on all aspects of quality of life.

About the Authors

N. I. Shova
Bekhterev National Medical Research Centre for Psychiatry and Neurology
Russian Federation

Natalia I. Shova – Postgraduate Student

RSCI SPIN-code: 1952-3043

3 Bekhterev Str., Saint Petersburg 192019

V. А. Mikhailov
Bekhterev National Medical Research Centre for Psychiatry and Neurology
Russian Federation

Vladimir A. Mikhailov – Dr. Med. Sc., Deputy Director for Innovative Scientific Development, Head of the International Department, Chief Researcher and Scientific Director of the Department of Treatment of Organic Mental Disorders and Epilepsy and Rehabilitation of Patients with Psychosomatic Disorders

ResearcherID: B-3272-2017; RSCI SPIN-code: 5563-1009

3 Bekhterev Str., Saint Petersburg 192019

G. V. Odintsova
Polenov Russian Research Neurosurgical Institute – a branch of Almazov National Medical Research Centre
Russian Federation

Galina V. Odintsova – Cand. Med. Sc., Head of the Research Laboratory of Epileptology

Scopus Author ID: 55510371000; ResearcherID: G-8940-2012; RSCI SPIN-code: 1303-4651

12 Mayakovskiy Str., Saint Petersburg 191014


1. Ambrumova A.G. Suicidal behavior as an object of complex study. In: Comprehensive research in suicidology: a collection of scientific papers. Moscow; 1986: 7–25 (in Russ.).

2. Bernert R.A., Hom M.A., Roberts L.W. A review of multidisciplinary clinical practice guidelines in suicide prevention: toward an emerging standard in suicide risk assessment and management, training and practice. Acad Psychiatry. 2014; 38 (5): 585–92.

3. Polozhiy B.S. Suicidal behavior (clinical, epidemiological, and ethno-cultural aspects). Moscow; 2010: 232 (in Russ.).

4. Marušić А., Roscar S., Zorko M., Sveticic J. Going beyond the bio-psycho-social boundaries in suicidology. Psychiat Danub. 2006; 18 (Suppl. 1): 7–8.

5. World Health Organisation. Preventing suicide: a global imperative. Geneva; 2014: 98.

6. Mann J.J., Waternaux C., Haas G.L., Malone K.M. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 1999; 156 (2): 181–97.

7. Harnod T., Lin C.L., Kao C.H. Evaluating clinical risk factors for suicide attempts in patients with epilepsy. J Affect Disord. 2018; 229: 79–84.

8. Harnod T., Lin C.L., Kao C.H. Prevalence of suicide attempts and their risk factors in school-aged patients with epilepsy: a population-based study. Eur Child Adolesc Psychiatry. 2018; 27 (8): 1047–53.

9. Abraham N., Buvanaswari P., Rathakrishnan R., et al. A meta-analysis of the rates of suicide ideation, attempts and deaths in people with epilepsy. Int J Environ Res Public Health. 2019; 16 (8): 1451.

10. Pompili M., Girardi P., Ruberto A., Tatarelli R. Suicide in the epilepsies: a meta-analytic investigation of 29 cohorts. Epilepsy Behav. 2005; 7 (2): 305–10.

11. Bell G.S., Mula M., Sander J.W. Suicidality in people taking antiepileptic drugs: What is the evidence? CNS Drugs. 2009; 23 (4): 281–92.

12. Hesdorffer D.C., Ishihara L., Webb D.J., et al. Occurrence and recurrence of attempted suicide among people with epilepsy. JAMA Psychiatry. 2016; 73 (1): 80–6.

13. Pompili M., Tatarelli R., Girardi P., et al. Suicide risk during anticonvulsant treatment. Pharmacoepidemiol Drug Saf. 2010; 19 (5): 525–8.

14. Bell G.S., Sander J.W. The epidemiology of epilepsy: the size of the problem. Seizure. 2001; 10 (4): 306–14.

15. Kalinin V.V. Suicidality and antiepileptic drugs: is there a link? Drug Saf. 2007; 30 (2): 123–42.

16. Pylaeva O.A., Mukhin K.Yu., Shatenshteyn A.A. Epilepsy and risk of suicide (a review). Russian Journal of Child Neurology. 2013; 8 (2): 23–40. (in Russ.).

17. Hesdorffer D.C., Kanner A.M. The FDA alert on suicidality and antiepileptic drugs: fire and false alarm? Epilepsia. 2009; 50 (5): 978–86.

18. Kwon O.Y., Park S.P. Frequency of affective symptoms and their psychosocial impact in Korean people with epilepsy: a survey at two tertiary care hospitals. Epilepsy Behav. 2013; 26 (1): 51–6.

19. Buljan R., Santić A.M. Suicide attempts in hospital-treated epilepsy patients. Acta Clin Croat. 2011; 50 (4): 485–90.

20. Trimble M.R. Antiepileptic drugs and suicide. In: Trimble M.R., Schmitz B. (Eds.) The neuropsychiatry of epilepsy. Cambridge: Cambridge University Press; 2011: 143–54.

21. Shova N.I., Mikhailov V.A., Odintsova G., et al. Spectrum of psychological disorders in patients with pharmacoresistant epilepsy under conditions of a neurosurgical hospital. Polenov Russian Neurosurgical Journal. 2019; 11 (4): 53–8 (in Russ.).

22. Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007; 30 (7): 555–67.

23. Mula M., Kanner A.M., Schmitz B., Schachter S. Antiepileptic drugs and suicidality: an expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology. Epilepsia. 2013; 54 (1): 199–203.

24. Odintsova G., Chugunova A., Koroleva N. Changes of spectrum antiepileptic drug during ten years. Epilepsia. 2009; 50 (Suppl. 4): 193.

25. Mikhalovska-Karlova E.P., Mikhailova O.N., Karlov V.A. Epilepsy treatment in patients with comorbid suicidality: ethical, clinical and social aspects. Epilepsia. 2018; 59 (12, Suppl. 3): 533.


For citations:

Shova N.I., Mikhailov V.А., Odintsova G.V. “Suicidal passport” for epilepsy. Epilepsy and paroxysmal conditions. 2020;12(4):226-236. (In Russ.)

Views: 827

ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)